We addressed some interesting topics like:

- What does it mean to eat healthily?

- How well do European consumers understand healthy eating?

- How do European regulations support healthy eating for consumers?

- Is healthy eating truly unaffordable?

- What effective strategies can encourage children to eat healthier foods?

- How can we make nutritious food more appealing and enjoyable?

- How are the interventions in the Obelisk Project addressing healthy eating and food affordability?

If you're interested in finding out the answers to these questions, don't miss this episode!

If you would like to see the video with captions go to our web page: Resources

The Obelisk Project has taken a step forward in the fight against childhood obesity by launching its first-ever podcast. Titled "Let's Talk about Obesity and Youth," it's aimed at starting a conversation about the underlying causes of childhood obesity and its impact on the well-being of children and society at large.

In this episode, our host, Kate Wall, Nutritionist and Associate Consultant at Beta Technology will lead the conversation where we will delve deeper into childhood obesity. We will analyse the underlying causes and discuss the impact on children's well-being and consequences in later life. We will debate the urgency of addressing this issue and explore potential solutions for a healthier and more informed approach to tacking childhood obesity.

https://obeliskproject.eu/

Episode guests

In todays show, we are joined by Amélie Bonnefond and Phillippe Froguel from Inserm in France, joint coordinators of the Obelisk project. 

Amélie graduated as PhD from University of Lille in 2010. Her scientific career has been focused on the dissection of the genetic aetiologies of type 2 diabetes and obesity to elucidate their pathophysiology towards a better stratification of the patients and a putative identification of new drug targets. She is Director of Research (Inserm) and heads a team tackling “Metabolic functional (epi)genomics and their abnormalities in type 2 diabetes and related disorders”. She is also the current scientific director of the PIA-funded EquipEx LIGAN-PM platform dedicated to the use of next-generation sequencing in precision medicine. She has published >150 peer-reviewed scientific papers (H Index: 59 [Google Scholar]).

Philippe is a renowned geneticist known for his contributions to the field of diabetes research. He has made significant discoveries in the genetic basis of obesity and type 2 diabetes. Philippe has identified several gene variants associated with these conditions, shedding light on their underlying mechanisms. He has published extensively, received numerous awards, and held prestigious academic positions. His research has paved the way for personalized medicine approaches in diabetes and obesity, offering insights into prevention, diagnosis, and treatment strategies. He has published >800 peer-reviewed scientific papers (H Index: 184 [Google Scholar]).